Annals of Dermatology

该期刊的审稿人政策要求审稿人对稿件及其所含信息严格保密，不得公开讨论作者的工作，不得在稿件发表前占用作者的观点，不得将稿件留作个人使用，并在提交审稿意见后销毁稿件副本；根据ICMJE建议，审稿人若在审稿中寻求实习生或同事的协助，应在提交给编辑的书面意见中说明这些人的贡献。 模型中文摘要

Reviewers should keep manuscripts and the information they contain strictly confidential. Reviewers must not publicly discuss authors’ work and must not appropriate authors’ ideas before the manuscript is published. Reviewers must not retain the manuscript for their personal use and should destroy copies of manuscripts after submitting their reviews. In accordance with ICMJE Recommendations, revie…

该期刊遵循ICMJE的《医学期刊学术著作的开展、报告、编辑和出版建议》以及韩国医学期刊编辑协会的《医学期刊良好出版实践指南（第3版）》，所有被指定为作者的人员均应具备作者资格，具备资格者均应被列出，且每位作者应充分参与该工作。 模型中文摘要

Ann Dermatol follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals by the International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org) and the Good Publication Practice Guidelines for Medical Journals 3rd by the Korean Association of Medical Journal Editors(KAMJE, https://www.kamje.or.kr/board/view?b_name=bo_publi…

该期刊的利益冲突政策要求作者披露支持其工作的所有资金来源以及作者的所有机构或公司隶属关系；为避免歧义，作者必须明确说明目前及过去3年内是否存在潜在利益冲突，包括但不限于咨询安排、股票或其他股权、股票期权、专利许可安排、为开展或宣传研究而支付的款项以及与投资公司的咨询关系，并需提交填写完成的利益冲突表。 模型中文摘要

Authors are responsible for disclosing all funding sources that supported their work as well as all institutional or corporate affiliations of the authors. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist currently and over the past 3 years. These include but are not limited to consultant arrangements, stock or other equity ownership, stock options…

该期刊的数据可用性政策支持在保护患者隐私和保密的前提下公开所有数据以促进研究可重复性，鼓励作者在稿件中包含数据可用性声明（如数据存储库链接），作者也可选择说明数据无法共享的原因；对于临床试验，该期刊接受ICMJE的数据共享声明政策建议，所有报告临床试验结果的稿件均应附有数据共享声明。 模型中文摘要

a. Ann Dermatol supports the principle that all data should be made available to facilitate research reproducibility, while protecting patient privacy and confidentiality. We encourage authors to include a data availability statement in the manuscript (eg, a link to a data repository). Authors also have the option to explain why data may not be shared. b. Clinical trials : Ann Dermatol accepts the…

Upon identifying or suspecting misconduct, the Committee shall collect sufficient information to decide on the infringement, and authors will be given the opportunity to respond to any allegations. In the case of confirmed violations, the following actions may be taken: 1. Issuing a formal letter to the authors regarding the misconduct and providing ethical guidance. 2. Sending an official letter …

该期刊的许可政策要求所有被接受稿件的作者签署期刊的《作者责任与许可协议》表格，并通过传真（+82-2-3472-4203）或电子邮件（dermajournal@anndermatol.org）提交；发表在Ann Dermatol上的文章版权遵循知识共享署名-非商业性使用许可协议。 模型中文摘要

All authors of accepted manuscripts must sign a copy of the Journal's “Authorship Responsibility and License Agreement” form and submit it to Fax: no. +82-2-3472-4203 or e-mail it to dermajournal@anndermatol.org. For the copyrights of the contributions published in Ann Dermatol (see Creative Commons; Attribution-Noncommercial) at http://creativecommons.org.

该期刊的开放获取政策规定，Ann Dermatol是开放获取期刊，经同行评审接受的文章在发表后立即在期刊网站上免费向全球任何用户提供，无需额外付费；文章根据知识共享署名-非商业性使用许可协议（CC BY-NC 4.0）发布，允许在注明原文出处的情况下进行不受限制的非商业性使用、分发和复制。 模型中文摘要

Ann Dermatol is an open access journal. Accepted peer-reviewed articles are freely available on the journal website for any user, worldwide, immediately upon publication without additional charge. Articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distrib…

- Peer review policy and process The Editorial Office of Ann Dermatol reviews all manuscripts received and a manuscript is previewed for its format. If the structure of the manuscript is not sufficient for the instructions in Authors’ guideline, then the manuscript will not accepted. The manuscript which satisfies the basic structural format is sent to Editor-in-Chief for evaluating academic relev…

该期刊的重复发表政策将重复发表定义为“在未注明原始来源的情况下，多次报告（发表或试图发表）实质上相同的工作”，其实质相似的报告特征包括：至少有一名作者为所有报告的共同作者（若无共同作者，则更可能是抄袭而非重复发表）、研究对象或研究人群相同或重叠、方法通常完全相同或几乎相同、结果和解释几乎没有或没有差异。 模型中文摘要

Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s).” Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant pu…

Ann Dermatol accepts papers submitted in not-for-profit preprint servers (e.g., arXiv, bioRxiv, MedRxiv, or similar platforms). Although the paper’s eligibility to Ann Dermatol will not be limited, its novelty may be undermined if the work is widely recognized through media or other means. Authors posting their preprint work in Ann Dermatol are required to disclose the following policies; 1) Detai…

该期刊的临床试验注册政策鼓励作者查阅与其具体研究设计相关的报告指南，以免遗漏重要信息，并推荐EQUATOR Network和美国国立卫生研究院/国家医学图书馆作为报告指南的良好来源。 模型中文摘要

Authors are encouraged to consult the reporting guidelines relevant to their specific study design in order not to omit important information. A good source of reporting guidelines is the EQUATOR Network (http://www.equator-network.org/home/) and the United States National Institutes of Health/ National Library of Medicine (http://www.nlm.nih.gov/services/research_report_guide.html).